Shares of Amprius Technologies, Inc. (NYSE:AMPX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten brokerages that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $21.6667.
AMPX has been the topic of a number of analyst reports. William Blair restated an “outperform” rating on shares of Amprius Technologies in a research report on Friday, March 6th. Cantor Fitzgerald boosted their price objective on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Wall Street Zen cut shares of Amprius Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a research report on Monday, April 20th. Finally, Clear Str assumed coverage on shares of Amprius Technologies in a research note on Tuesday, June 2nd. They set a “strong-buy” rating and a $33.00 target price on the stock.
View Our Latest Analysis on AMPX
Amprius Technologies Trading Down 7.5%
Amprius Technologies (NYSE:AMPX – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Amprius Technologies had a negative net margin of 43.98% and a negative return on equity of 17.48%. The firm had revenue of $28.54 million during the quarter, compared to analysts’ expectations of $25.72 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. Equities analysts predict that Amprius Technologies will post -0.07 EPS for the current year.
Insider Activity
In other news, CTO Constantin Ionel Stefan sold 3,208 shares of Amprius Technologies stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $17.19, for a total transaction of $55,145.52. Following the sale, the chief technology officer owned 801,310 shares of the company’s stock, valued at approximately $13,774,518.90. The trade was a 0.40% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Donald R. Dixon sold 17,895 shares of Amprius Technologies stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $17.90, for a total transaction of $320,320.50. Following the sale, the director directly owned 484,380 shares in the company, valued at $8,670,402. The trade was a 3.56% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 2,471,724 shares of company stock worth $41,282,649. 5.10% of the stock is owned by company insiders.
Institutional Investors Weigh In On Amprius Technologies
A number of large investors have recently modified their holdings of the stock. EWA LLC boosted its stake in shares of Amprius Technologies by 3.8% during the 4th quarter. EWA LLC now owns 19,958 shares of the company’s stock valued at $157,000 after purchasing an additional 723 shares in the last quarter. Victory Capital Management Inc. boosted its stake in shares of Amprius Technologies by 14.7% during the 3rd quarter. Victory Capital Management Inc. now owns 11,817 shares of the company’s stock valued at $124,000 after purchasing an additional 1,516 shares in the last quarter. Graham Capital Management L.P. boosted its stake in shares of Amprius Technologies by 3.2% during the 4th quarter. Graham Capital Management L.P. now owns 49,596 shares of the company’s stock valued at $391,000 after purchasing an additional 1,551 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in shares of Amprius Technologies by 5.1% during the 4th quarter. The Manufacturers Life Insurance Company now owns 33,280 shares of the company’s stock valued at $263,000 after purchasing an additional 1,621 shares in the last quarter. Finally, First Trust Advisors LP boosted its stake in shares of Amprius Technologies by 6.7% during the 4th quarter. First Trust Advisors LP now owns 32,744 shares of the company’s stock valued at $258,000 after purchasing an additional 2,066 shares in the last quarter. Institutional investors own 5.04% of the company’s stock.
Amprius Technologies Company Profile
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Recommended Stories
- Five stocks we like better than Amprius Technologies
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
